Drug treatment involves the implementation of insulin therapy, utilizing either human insulin, insulin analogs, or an expanding array of antihyperglycemic agents to achieve glycemic control, thus minimizing the effects of recurrent hypoglycemia and hyperglycemia. The gene discussed is INS; the disease is Hyperglycemia.